Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
14,292 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Impact of body composition on clinical outcomes in patients with hepatocellular carcinoma: A systematic review and meta-analysis.
Pinto E, Barberio B, Gambato M, Ferdinande K, Marchese E, Ferrarese A, Germani G, Senzolo M, Russo FP, Burra P, Zanetto A. · Hepatol Commun · 2026 · cited 0 timesmeta-analysis, systematic review
- Interleukin-6 as a prognostic biomarker in hepatocellular carcinoma treated with systemic therapy: a systematic review and meta-analysis.
Perfilyeva YV, Abdolla N, Kali A, Tleulieva R, Perfilyeva AV, Skiba YA, Ostapchuk YO. · Future Oncol · 2026 · cited 0 timesmeta-analysis, systematic review
- Cryoablation versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
Mao K, Wang Y, Yao W, Ding J, Ye Z, Ye Y, Zhu R. · Int J Hyperthermia · 2026 · cited 0 timesmeta-analysis, systematic review
- Spleen management in hepatectomy for hepatocellular carcinoma with hypersplenism: a systematic review and network meta-analysis.
Liu B, Jia G, Miao J, Li X, Zhang J, Song C, Chen J. · Eur J Surg Oncol · 2026 · cited 0 timessystematic review, network meta-analysis
- Intratumoral and Peritumoral Features for Predicting Microvascular Invasion in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis.
Zhao B, Yu Y, Yang Y, Wang L, Li J. · J Vis Exp · 2026 · cited 0 timesvideo-audio media, meta-analysis
- Peri-procedural Lidocaine Administration for Radiofrequency Ablation of Hepatocellular Carcinoma: A Pilot Study.
Sargarovschi S, Sparchez ZA, Alexa AL, Paunescu A, Rucsanda I, Valean D, Benea A, Ionescu D. · J Gastrointestin Liver Dis · 2026 · cited 0 timesrandomized controlled trial
- Machine Perfusion and Oncologic Outcomes After Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Kim SH, An BH, Lee JA, Jeong GW. · Curr Oncol · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- The effect of TIPS on the development of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis.
Xu X, Jiang M, Fu Y, Meng Q. · BMC Gastroenterol · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Resection rates after conversion therapy for initially unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Ouyang X, Li J, Liang P, Wang Y, Liu Y, Cheng Z, Che P. · Front Oncol · cited 0 timesOpen accesssystematic-review, review
- Stereotactic body radiation therapy for hepatocellular carcinoma larger than 5 cm: a systematic review and meta-analysis.
He J, Wang X, Zuo T, Wang L, Wang Y, Zheng S, Zhou R, Zhang Y. · Jpn J Radiol · 2026 · cited 0 timesmeta-analysis, systematic review
- Circulating tumor DNA and recurrence after curative-intent treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Abdelrahim SA, Gahtani RM, Alqassimi S, Alsaweed M, Miraj M, Ahsan M, Mallick AK, Khan AU. · Surg Oncol · 2026 · cited 0 timesmeta-analysis, systematic review
- The role of exosomal microRNAs in detecting hepatocellular carcinoma: A systematic review and meta-analysis.
Zuo Z, Yang M, Yin X, Tang W, Du L, Guo Y. · Clin Chim Acta · 2026 · cited 0 timesmeta-analysis, systematic review
- Global Underutilization of Antiviral Therapy and Survival Outcomes in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of 78 Studies and 68,243 Patients.
Kudaravalli S, Yan T, Tseng CH, Hsu YC, Li X, Wu Y, Chen B, Gao X, Gao S, Ren D, Qian X, Sands W, Cheung R, Nguyen MH. · J Viral Hepat · 2026 · cited 0 timesmeta-analysis, systematic review
- Association between antibiotic exposure and survival outcomes in hepatocellular carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Chen S, Chen S, Li Y, Su J, Yu C, Xu C, Li Q, Wu Q, Sun C. · PeerJ · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Resection rates after conversion therapy for initially unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
Ouyang X, Li J, Liang P, Wang Y, Liu Y, Cheng Z, Che P. · Front Oncol · 2026 · cited 0 timessystematic review
- Second-line treatment selection for advanced hepatocellular carcinoma: a network meta-analysis with reconstructed survival curves and integrated benefit-risk assessment.
Li X, Nie G, Wang Y, Xu J, Yang J, He E, Liu G, Li B, Lu J. · Front Immunol · 2026 · cited 0 timesOpen accessresearch support, non-u.s. gov't, systematic review
- Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma: The Phase 3 TORCH Randomized Clinical Trial.
Lyu N, Yi JZ, Wu XT, Zhang YM, Pan T, Mu LW, Chen S, Wang JL, Xu J, Tan GJ, Zhang YN, Gao ZQ, Ou-Yang ZX, Wu WJ, Song YJ, Deng HJ, He M, Jiang YQ, Chen QF, Li JB, Shi M, Chen MS, Zhao M. · JAMA Oncol · 2026 · cited 2 timesclinical trial, phase iii, multicenter study
- A Meta-Analysis of Radiomics-Based Models for Preoperative Assessment of Ki-67 Status in Hepatocellular Carcinoma.
Jia Y, Yu B, Ding L, Li X, Ru Y, Sun H, Song D, Huang C, Zhan J, Yin B, Li D. · J Vis Exp · 2026 · cited 0 timesvideo-audio media, meta-analysis
- Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in Patients with Advanced Hepatocellular Carcinoma.
Sun X, Gao W, Shou C, Yan J, Fu Q, Zheng Y, Liu L, Zhai Y, Tong Z, Zhang H, Li B, Lin M, Zhu X, Wang Y, Yuan D, Bao X, Dai X, Luo Y, Jiang H, Wang H, Zhao P, Zhao Q, Fang W, Li Z, Liang T. · Clin Cancer Res · 2026 · cited 0 timesclinical trial, phase i
- Diagnostic accuracy of surveillance tests for hepatocellular carcinoma in cirrhosis: a systematic review and network meta-analysis.
Rogers G, Derezea E, Sadler L, Wang H, Cramp ME, Ryder SD, Watt K, Whiting P, Rogers M, Bell J, Oppe F, Stein K, Welton NJ, Jones HE. · BMJ Open Gastroenterol · 2026 · cited 0 timesOpen accesssystematic review, network meta-analysis
- Clinicopathological significance of Gli1 expression in hepatocellular carcinoma: a meta-analysis.
Li S, Chen M, Zhang S, Xu Z, Wang H. · Sci Rep · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Quantitative Contrast-enhanced Ultrasound Evaluation of Hepatocellular Carcinoma Radioembolization.
Wessner CE, Chong W, Berreby G, Delaney LJ, Forsberg F, Lyshchik A, O'Kane P, Liu JB, Anton K, Topper SR, Civan J, Maley W, Keith SW, Shaw CM, Eisenbrey JR. · Invest Radiol · 2026 · cited 0 timesclinical trial
- Pentraxin-3, a complementary biomarker in hepatocellular carcinoma: Systematic review and Meta-analysis.
Amdetsion GY, Murali AR, Pan CW, Miranda C, Sueldo A, Tebeje HG, Guifarro D, Kwei-Nsoro R, Kotwal V. · Clin Chim Acta · 2026 · cited 0 timesmeta-analysis, systematic review
- MRI-based radiomics for noninvasive prediction of GPC3 expression in hepatocellular carcinoma: a systematic review and meta-analysis.
Gao R, Li X. · Front Oncol · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Diagnostic accuracy of circulating long noncoding RNAs in hepatocellular carcinoma: a systematic review and meta-analysis.
Babajani N, Saeedian B, Shirmard FO, Pourfaraji SM, Jodeiri F, Delavari A, Taheri E. · BMC Gastroenterol · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.